Akebia Therapeutics (AKBA) P/E (2014 - 2026)
Akebia Therapeutics (AKBA) P/E from Mar 31, 2014 to Jun 15, 2026. The TTM Akebia Therapeutics (AKBA) P/E is -12.21. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Akebia Therapeutics (AKBA)
| Year | P/E | Change |
|---|---|---|
| 2026 | -12.21 | -85.01% |
| 2025 | -81.41 | +1283.34% |
| 2024 | -5.89 | +44.71% |
| 2023 | -4.07 | +519.82% |
| 2022 | -0.66 | -51.55% |
| 2021 | -1.35 | -66.24% |
| 2020 | -4.01 | +48.74% |
| 2019 | -2.70 | -34.07% |
| 2018 | -4.09 | -50.91% |
| 2017 | -8.33 | +47.17% |
| 2016 | -5.66 | -45.30% |
| 2015 | -10.35 | -7.30% |
| 2014 | -11.17 | N/A |
Comparison Akebia Therapeutics (AKBA) P/E with competitors
Akebia Therapeutics (AKBA) P/E is -12.21.